✦ LIBER ✦

OC.01.1 DIFFERENTIAL DEGRADATION OF ANTI-TUMOR NECROSIS FACTOR-ALPHA AGENTS BY MATRIX METALLOPROTEINASE-12 IN INFLAMMATORY BOWEL DISEASE

✍ Scribed by P. Biancheri; A. Di Sabatino; L. Rovedatti; N. Ahmad; G. Corazza; T. MacDonald

Book ID: 119633622
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 58 KB
Volume: 42
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(10)60023-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

M1803 Differential Degradation of Anti-T

M1803 Differential Degradation of Anti-Tumor Necrosis Factor-α Agents by Matrix Metalloproteinase-12 in Inflammatory Bowel Disease

✍ Biancheri, Paolo; Di Sabatino, Antonio; Rovedatti, Laura; Ahmad, Nadja; Corazza, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

OC.06.7: EFFECT OF MATRIX METALLOPROTEIN

OC.06.7: EFFECT OF MATRIX METALLOPROTEINASE (MMP)-3, -8, -10 AND -12 ON THE STRUCTURE AND FUNCTION OF ANTI-TUMOR NECROSIS FACTOR-ALPHA AGENTS IN INFLAMMATORY BOWEL DISEASE

✍ P. Biancheri; A. Di Sabatino; S.A. Snoek; I. Joe-njoku; L. Rovedatti; N. Ahmad; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Contribution to the regulation of intest

Contribution to the regulation of intestinal matrix metalloProteinase expression by tumor necrosis factor alpha in inflammatory bowel disease

✍ Meijer, Martin J.W.; Van Duijin, Wim; Mieremet-Ooms, Marij A.C.; Van der Zon, An 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Effect of the anti-tumor necrosis factor

Effect of the anti-tumor necrosis factor-α antibody infliximab on the ex vivo mucosal matrix metalloproteinase–proteolytic phenotype in inflammatory bowel disease

✍ Martin J. Meijer; Marij A.C. Mieremet-Ooms; Wim van Duijn; Annie M. van der Zon; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB

## Background: Previous studies have shown an upregulation of matrix metalloproteinases (mmps) in intestinal tissue of patients with inflammatory bowel disease (ibd) and significant clinical improvement after administration of the anti-tnf-a antibody infliximab. the aims of our study were to determ

P.1.173: FORMATION OF NON-ORGAN SPECIFIC

P.1.173: FORMATION OF NON-ORGAN SPECIFIC AUTOANTIBODIES (NOSA) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) TREATED WITH ANTI-TUMOR NECROSIS FACTOR-ALPHA AGENTS

✍ I. Bravatà; M. Cappello; C. Randazzo; A. Licata; F. Barbaria; P.L. Almasio; A. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 84 KB